CN117457114B - Intelligent storage management method for western medicine pharmaceutical composition data - Google Patents
Intelligent storage management method for western medicine pharmaceutical composition data Download PDFInfo
- Publication number
- CN117457114B CN117457114B CN202311785210.1A CN202311785210A CN117457114B CN 117457114 B CN117457114 B CN 117457114B CN 202311785210 A CN202311785210 A CN 202311785210A CN 117457114 B CN117457114 B CN 117457114B
- Authority
- CN
- China
- Prior art keywords
- medicine
- drug
- pharmaceutical
- stored
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 324
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 55
- 238000007726 management method Methods 0.000 title claims abstract description 19
- 239000004615 ingredient Substances 0.000 claims abstract description 232
- 229940079593 drug Drugs 0.000 claims abstract description 167
- 230000000694 effects Effects 0.000 claims abstract description 36
- 230000003993 interaction Effects 0.000 claims abstract description 35
- 230000009471 action Effects 0.000 claims abstract description 19
- 239000000306 component Substances 0.000 claims description 126
- 238000000034 method Methods 0.000 claims description 49
- 239000006185 dispersion Substances 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 6
- 238000010606 normalization Methods 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 238000004364 calculation method Methods 0.000 claims description 3
- 239000005426 pharmaceutical component Substances 0.000 claims description 3
- 241000894007 species Species 0.000 description 18
- 241001632422 Radiola linoides Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/50—Molecular design, e.g. of drugs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Computing Systems (AREA)
- Theoretical Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Physics & Mathematics (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention relates to the technical field of data processing, in particular to an intelligent storage management method for western medicine pharmaceutical composition data, which comprises the following steps: acquiring pharmaceutical ingredient data to be stored; acquiring the possibility of interaction between each pharmaceutical ingredient in pharmaceutical ingredient data to be stored and each target pharmaceutical ingredient of each pharmaceutical ingredient; acquiring the discrete degree of the drug efficacy action of the pharmaceutical ingredient data to be stored according to the efficacy action degree of each pharmaceutical ingredient in the pharmaceutical ingredient data to be stored; and classifying and storing the pharmaceutical ingredient data to be stored according to the discrete degree of the efficacy action of the medicine. The invention ensures that the classified storage effect of the pharmaceutical ingredient data to be stored is better.
Description
Technical Field
The invention relates to the technical field of data processing, in particular to an intelligent storage management method for western medicine pharmaceutical composition data.
Background
With the rapid development of the pharmaceutical industry, the variety and quantity of drugs has been increasing explosively. Due to huge data volume of medicine components, the existing medicine storage management method is easy to have the problem of low efficiency in the medicine access process. Therefore, by reasonably clustering the medicine components, the related medicines are put together, and a doctor can quickly position the related medicines when inquiring a certain medicine, so that the retrieval efficiency is greatly improved, and the access efficiency is improved.
In the conventional iterative self-organizing clustering method, clustering is performed according to the discrete degree of multi-dimensional data, and in the drug data, because interactions may exist between drug components, that is, effects caused by the fact that some drug components are independently present and the components are combined with other drug components are different, if drugs are clustered according to the discrete degree of the drug components, different drugs cannot be well distinguished.
Disclosure of Invention
In order to solve the problems, the invention provides an intelligent storage management method for western medicine pharmaceutical ingredient data, which comprises the following steps:
acquiring to-be-stored pharmaceutical ingredient data, wherein the to-be-stored pharmaceutical ingredient data comprises a plurality of medicines, a plurality of medicine ingredients and the content of all the medicine ingredients in each medicine;
acquiring all target pharmaceutical ingredients of each pharmaceutical ingredient according to the number of simultaneous occurrence of each pharmaceutical ingredient and other pharmaceutical ingredients in pharmaceutical ingredient data to be stored; acquiring the possibility of interaction between each drug component and each target drug component of each drug component according to the content of each drug component in each drug;
obtaining the degree of efficacy of each drug component in each drug according to the possibility of interaction between each drug component and each target drug component of each drug component; acquiring the discrete degree of the efficacy effect of the medicine to be stored with the data of the pharmaceutical ingredients according to the efficacy effect degree of each medicine ingredient in each medicine;
and classifying and storing the pharmaceutical ingredient data to be stored according to the discrete degree of the efficacy action of the medicine.
Preferably, the method for obtaining all target pharmaceutical ingredients of each pharmaceutical ingredient according to the number of simultaneous occurrence of each pharmaceutical ingredient and other pharmaceutical ingredients in each pharmaceutical in the pharmaceutical ingredient data to be stored includes the following specific steps:
and for any one of the pharmaceutical ingredients in the pharmaceutical ingredient data to be stored, combining the pharmaceutical ingredients with other pharmaceutical ingredients in a non-repeated mode to obtain all pharmaceutical ingredient combinations of the pharmaceutical ingredients, counting the simultaneous occurrence times of each pharmaceutical ingredient combination in all medicines in the pharmaceutical ingredient data to be stored, eliminating pharmaceutical ingredient combinations with the occurrence times of 0, and marking all other pharmaceutical ingredients except the pharmaceutical ingredients in the rest pharmaceutical ingredient combinations as target pharmaceutical ingredients of the pharmaceutical ingredients.
Preferably, the method for obtaining the possibility of interaction between each drug component and each target drug component of each drug component according to the content of each drug component in each drug comprises the following specific steps:
acquisition of the firstSeed drug ingredient and->First->Probability of co-occurrence of species target pharmaceutical ingredient; acquiring simultaneous presence of->Seed drug ingredient and->First->The content proportion of the seed target drug changes; will be the firstSeed drug ingredient and->First->The probability of co-occurrence of target pharmaceutical ingredient and the simultaneous presence of +.>Seed drug ingredient and->First->The ratio of the content proportion change degree of the seed target medicine is recorded as a first ratio; taking the first ratio after linear normalization as the +.>Seed drug ingredient and->First->There is a possibility of interaction between the target pharmaceutical ingredients.
Preferably, the acquiring a firstSeed drug ingredient and->First->The specific formula of the probability of co-occurrence of the target drug components is as follows:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>Seed drug ingredient and->First->Probability of co-occurrence of species target pharmaceutical ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Total number of drugs seeded with the target drug ingredient; />Indicating the presence of +.>Total amount of drug of the seed drug component; />Indicating the presence of +.>First->Total amount of drug of the target drug component.
Preferably, the acquisition is concurrent with the firstMedicinal ingredients of species and->First->The specific formula of the content proportion change degree of the target medicine component is as follows:
in the method, in the process of the invention,indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The content ratio of the two medicinal components in all medicaments for the target medicinal components varies; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Total number of drugs seeded with the target drug ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>The content of the seed medicine component; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>First->The content of the target pharmaceutical ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Of all drugs of the target drug ingredient +.>Content of seed medicine component and->First->Average value of the ratio of the contents of the target pharmaceutical ingredient.
Preferably, the method for obtaining the degree of efficacy of each pharmaceutical ingredient in each drug according to the possibility of interaction between each pharmaceutical ingredient and each target pharmaceutical ingredient of each pharmaceutical ingredient comprises the following specific methods:
obtaining the efficacy action weight of each medicine component in each medicine according to the possibility of interaction between each medicine component and each target medicine component of each medicine component; the first of the pharmaceutical composition data to be storedThe seed medicine component is at->The calculation method of the efficacy and effect degree of the medicine comprises the following steps:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The weight of the efficacy of the seed medicine; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The content of the medicine.
Preferably, the method for obtaining the efficacy action weight of each drug component in each drug according to the possibility of interaction between each drug component and each target drug component of each drug component comprises the following specific steps:
for the first of the pharmaceutical composition data to be storedDrug of the seed>A medicinal ingredient of the species, in->Obtaining the +.f from all the medicinal components of the seed medicine>All target pharmaceutical ingredients of the seed pharmaceutical ingredient, will be +.>Seed drug ingredient and->The mean value of the possibility of interaction between all target pharmaceutical ingredients of the species pharmaceutical ingredient is taken as +.>The seed medicine component is at->The weight of the efficacy of the medicine.
Preferably, the method for obtaining the dispersion degree of the efficacy of the drug to be stored according to the efficacy of each drug component in each drug comprises the following specific steps:
obtaining the first data of the pharmaceutical composition to be storedThe seed medicine component is at->The method for calculating the discrete degree of the efficacy effect of the medicine to be stored with the pharmaceutical composition data comprises the following steps of:
in the method, in the process of the invention,representing the degree of dispersion of the pharmaceutical efficacy effect of the pharmaceutical ingredient data to be stored; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The difference of efficacy in the seed medicines; />Representing the total number of all pharmaceutical ingredients in the pharmaceutical ingredient data to be stored; />Representing the total number of all drug classes in the pharmaceutical composition data to be stored;representing a linear normalization function.
Preferably, the obtaining the first pharmaceutical ingredient data to be storedThe seed medicine component is at->The specific formula of the difference of efficacy in the medicine is as follows:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The average value of the degree of the efficacy of the drug ingredients in all drugs.
Preferably, the classifying and storing the pharmaceutical composition data to be stored according to the discrete degree of the efficacy of the drug comprises the following specific steps:
if the degree of dispersion of the drug efficacy of the pharmaceutical composition data to be stored is smaller thanThe pharmaceutical composition data to be stored is recorded as target pharmaceutical storage data; if the dispersion degree of the drug efficacy of the pharmaceutical ingredient data to be stored is greater than or equal to +.>The method comprises the steps of treating the storage through an iterative self-organizing clustering algorithmClustering the pharmaceutical ingredient data to obtain a plurality of clusters, and marking the clusters as first clusters; for any one first cluster, if the dispersion degree of the drug efficacy action of the first cluster is greater than or equal to +.>Clustering the first cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the first cluster, and marking the clusters as second cluster clusters; for any one of the second cluster of the first cluster, if the degree of dispersion of the drug efficacy effect of the second cluster is greater than or equal to +.>Clustering the second cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the second cluster; and so on, until the degree of dispersion of the drug efficacy effect of all clusters is less than +.>Until that, each cluster obtained is taken as target medicine storage data; all of the drug components in each target drug storage data are stored together in a database.
The technical scheme of the invention has the beneficial effects that: according to the invention, the degree of efficacy action of each medicine component in each medicine is obtained according to the possibility of interaction between each medicine component and other medicine components; acquiring the discrete degree of the efficacy effect of the medicine to be stored with the data of the pharmaceutical ingredients according to the efficacy effect degree of each medicine ingredient in each medicine; classifying and storing the pharmaceutical composition data to be stored according to the discrete degree of the efficacy action of the medicine; the classifying and storing effect of the to-be-stored pharmaceutical ingredient data is better, and the pharmaceutical ingredients with different effects are accurately distinguished.
Drawings
In order to more clearly illustrate the embodiments of the invention or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, it being obvious that the drawings in the following description are only some embodiments of the invention, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
Fig. 1 is a flow chart of steps of an intelligent storage management method for western medicine component data.
Detailed Description
In order to further explain the technical means and effects adopted by the invention to achieve the preset aim, the following is a detailed description of specific implementation, structure, characteristics and effects of the intelligent storage management method for western medicine pharmaceutical ingredient data according to the invention in combination with the accompanying drawings and the preferred embodiment. In the following description, different "one embodiment" or "another embodiment" means that the embodiments are not necessarily the same. Furthermore, the particular features, structures, or characteristics of one or more embodiments may be combined in any suitable manner.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
The following specifically describes a specific scheme of the intelligent storage management method for western medicine pharmaceutical composition data provided by the invention with reference to the accompanying drawings.
Referring to fig. 1, a flowchart illustrating steps of a method for intelligently storing and managing western medicine component data according to an embodiment of the present invention is shown, and the method includes the following steps:
step S001: and acquiring the data of the pharmaceutical ingredients to be stored.
It should be noted that, the pharmaceutical manufacturer will generally provide detailed information about the pharmaceutical of its product, including the formulation of the pharmaceutical and its formulation composition.
Specifically, in order to implement the intelligent storage management method for western medicine component data provided in this embodiment, first, the pharmaceutical component data to be stored needs to be collected, and the specific process is as follows:
the pharmaceutical composition data to be stored is acquired by a pharmaceutical manufacturer, and contains a plurality of medicines, a plurality of medicine compositions and the content of the medicine composition corresponding to each medicine composition of each medicine.
So far, the pharmaceutical composition data to be stored are obtained through the method.
Step S002: the possibility of interaction between each pharmaceutical ingredient in the pharmaceutical ingredient data to be stored and each target pharmaceutical ingredient of each pharmaceutical ingredient is acquired.
It should be noted that, in the drug data, since there is an interaction between certain drug components, for example, two different drugs interact in vivo, the effect thereof may be enhanced, which may result in an effect different from that when each drug is used alone, and the effect is different, so that it is necessary to analyze the possibility of interaction between the two drugs according to the ratio of the drug components in each drug and the occurrence probability thereof.
Specifically, for any one of the pharmaceutical ingredients in the pharmaceutical ingredient data to be stored, carrying out non-repeated pairwise combination on the pharmaceutical ingredients and other pharmaceutical ingredients to obtain all pharmaceutical ingredient combinations of the pharmaceutical ingredients, counting the simultaneous occurrence times of each pharmaceutical ingredient combination in all medicines in the pharmaceutical ingredient data to be stored, eliminating pharmaceutical ingredient combinations with the occurrence times of 0, and marking all the pharmaceutical ingredients except the pharmaceutical ingredients in the rest pharmaceutical ingredient combinations as target pharmaceutical ingredients of the pharmaceutical ingredients; and further obtaining all target pharmaceutical ingredients for each pharmaceutical ingredient in the pharmaceutical ingredient data to be stored.
It should be noted that, if there is an interaction between two pharmaceutical ingredients, the two pharmaceutical ingredients will be in pairs in most cases, and the ratio of the two pharmaceutical ingredients should be relatively close in different drugs, so that the higher the probability of occurrence of the pharmaceutical combination, the smaller the ratio change of the two pharmaceutical ingredients, and the higher the probability of interaction of the pharmaceutical combination. Thus, the probability that there is an interaction between two pharmaceutical ingredients is calculated from the ratio of the two pharmaceutical ingredients and the probability of occurrence of the combination of the pharmaceutical ingredients.
Specifically, the first item of the pharmaceutical composition data to be storedSeed drug ingredient and->First->The calculated expression that there is a possibility of interaction between the target pharmaceutical ingredients is:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>Seed drug ingredient and->First->The possibility of interaction exists between the target pharmaceutical ingredients; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Total number of drugs seeded with the target drug ingredient; />Indicating the presence of +.>Total amount of drug of the seed drug component; />Indicating the presence of +.>First->Total number of drugs seeded with the target drug ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>The content of the seed medicine component; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>First->The content of the target pharmaceutical ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Of all drugs of the target drug ingredient +.>Content of seed medicine component and->First->Average value of the ratio of the contents of the target pharmaceutical ingredient; />Representing a linear normalization function.
It should be noted that the number of the substrates,indicate->Seed drug ingredient and->First->The probability of co-occurrence of the target drug components is higher, and the probability of interaction is lower;indicating the simultaneous presence of->Medicinal ingredients of species and->First->The smaller the ratio of the target pharmaceutical ingredients is, the more likely the two are to have interaction, and the less likely the two are to have interaction.
Up to this point, the possibility of interaction between each pharmaceutical ingredient in the pharmaceutical ingredient data to be stored and each target pharmaceutical ingredient of each pharmaceutical ingredient is obtained by the above-described method.
Step S003: and obtaining the discrete degree of the efficacy action of the medicines in the pharmaceutical ingredient data to be stored according to the efficacy action degree of each pharmaceutical ingredient in the pharmaceutical ingredient data to be stored.
1. The degree of efficacy of each pharmaceutical ingredient in each drug to be stored in the pharmaceutical ingredient data is obtained.
It should be noted that if there is an interaction between a certain pharmaceutical ingredient and other drugs, i.e. if certain pharmaceutical ingredients are put together, there is a promoting effect, i.e. one of the pharmaceutical ingredients will enhance the absorption rate of the other pharmaceutical ingredient, i.e. if the more likely there is an interaction between a certain pharmaceutical ingredient and other pharmaceutical ingredient, the efficacy of the drug will be closer to that of the pharmaceutical ingredient. Therefore, in differentiating a drug according to the efficacy of the drug, it is necessary to calculate the degree of dispersion of the drug efficacy effect of the data of the pharmaceutical ingredient to be stored according to the possibility of interaction between the pharmaceutical ingredients in the pharmaceutical ingredient and the content of the pharmaceutical ingredient.
Specifically, for the first item in the pharmaceutical composition data to be storedDrug of the seed>A medicinal ingredient of the species, in->Obtaining the +.f from all the medicinal components of the seed medicine>All target pharmaceutical ingredients of the seed pharmaceutical ingredient, will be +.>Seed drug ingredient and->The mean value of the possibility of interaction between all target pharmaceutical ingredients of the species pharmaceutical ingredient is taken as +.>The seed medicine component is at->The weight of the efficacy of the seed medicine; then the +.o. in the pharmaceutical composition data to be stored>The seed medicine component is at->The calculation method of the efficacy and effect degree of the medicine comprises the following steps:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The weight of the efficacy of the seed medicine; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The content of the medicine.
It should be noted that the first judgment is neededWhether or not there is a seed medicineFirst->If the medicine component exists, continuing to calculate downwards, if the medicine component does not exist, directly enabling the +.>The seed medicine component is at->The degree of efficacy of the seed medicine is 0 +.>No. I in seed medicine>The greater the weight of the efficacy of the seed medicinal ingredient is, the +.>No. I in seed medicine>The greater the content of a pharmaceutical ingredient in the drug, the greater the efficacy of the pharmaceutical ingredient in the drug.
To this end, the degree of efficacy effect that each pharmaceutical ingredient plays in each drug in the pharmaceutical ingredient data to be stored is obtained.
2. And obtaining the dispersion degree of the drug efficacy effect of the to-be-stored pharmaceutical composition data.
Specifically, the method for calculating the discrete degree of the drug efficacy effect of the pharmaceutical composition data to be stored comprises the following steps:
in the method, in the process of the invention,representing the degree of dispersion of the pharmaceutical efficacy effect of the pharmaceutical ingredient data to be stored; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The difference of efficacy in the seed medicines; />Representing the total number of all pharmaceutical ingredients in the pharmaceutical ingredient data to be stored; />Representing the total number of all drug classes in the pharmaceutical composition data to be stored; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The average value of the efficacy degrees of the seed medicine components in all seed medicines;representing a linear normalization function.
So far, the dispersion degree of the drug efficacy effect of the drug ingredient data to be stored is obtained through the method.
Step S004: and classifying and storing the pharmaceutical ingredient data to be stored according to the discrete degree of the efficacy action of the medicine.
Specifically, if the dispersion degree of the drug efficacy effect of the pharmaceutical composition data to be stored is smaller thanThe pharmaceutical composition data to be stored is recorded as target pharmaceutical storage data; if the dispersion degree of the drug efficacy of the pharmaceutical ingredient data to be stored is greater than or equal to +.>Clustering the pharmaceutical composition data to be stored through an iterative self-organizing clustering algorithm to obtain a plurality of clustering clusters, and marking the clustering clusters as first clustering clusters; for any one first cluster, if the dispersion degree of the drug efficacy action of the first cluster is greater than or equal to +.>Clustering the first cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the first cluster, and marking the clusters as second cluster clusters; for any one of the second cluster of the first cluster, if the degree of dispersion of the drug efficacy effect of the second cluster is greater than or equal to +.>Clustering the second cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the second cluster; and so on, until the degree of dispersion of the drug efficacy effect of all clusters is less than +.>Until that, each cluster obtained is taken as target drug storage data.
The iterative self-organizing clustering algorithm is an existing algorithm, and the embodiments are not described herein in detail.
Further, all the pharmaceutical ingredients in each target pharmaceutical storage data are stored together in a database.
This embodiment is completed.
The above description is only of the preferred embodiments of the present invention and is not intended to limit the invention, but any modifications, equivalent substitutions, improvements, etc. within the principles of the present invention should be included in the scope of the present invention.
Claims (9)
1. The intelligent storage management method for western medicine component data is characterized by comprising the following steps of:
acquiring to-be-stored pharmaceutical ingredient data, wherein the to-be-stored pharmaceutical ingredient data comprises a plurality of medicines, a plurality of medicine ingredients and the content of all the medicine ingredients in each medicine;
acquiring all target pharmaceutical ingredients of each pharmaceutical ingredient according to the number of simultaneous occurrence of each pharmaceutical ingredient and other pharmaceutical ingredients in pharmaceutical ingredient data to be stored; acquiring the possibility of interaction between each drug component and each target drug component of each drug component according to the content of each drug component in each drug;
obtaining the degree of efficacy of each drug component in each drug according to the possibility of interaction between each drug component and each target drug component of each drug component; acquiring the discrete degree of the efficacy effect of the medicine to be stored with the data of the pharmaceutical ingredients according to the efficacy effect degree of each medicine ingredient in each medicine;
classifying and storing the pharmaceutical ingredient data to be stored according to the discrete degree of the efficacy action of the medicine;
according to the degree of efficacy action of each pharmaceutical ingredient in each drug, the discrete degree of drug efficacy action of the pharmaceutical ingredient data to be stored is obtained, and the specific method comprises the following steps:
obtaining the first data of the pharmaceutical composition to be storedThe seed medicine component isFirst->The method for calculating the discrete degree of the efficacy effect of the medicine to be stored with the pharmaceutical composition data comprises the following steps of:
in the method, in the process of the invention,representing the degree of dispersion of the pharmaceutical efficacy effect of the pharmaceutical ingredient data to be stored; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The difference of efficacy in the seed medicines; />Representing the total number of all pharmaceutical ingredients in the pharmaceutical ingredient data to be stored; />Representing the total number of all drug classes in the pharmaceutical composition data to be stored; />Representing a linear normalization function.
2. The intelligent storage management method for western medicine component data according to claim 1, wherein the specific method for obtaining all target medicine components of each medicine component according to the number of simultaneous occurrence of each medicine component and other medicine components in the medicine component data to be stored comprises the following steps:
and for any one of the pharmaceutical ingredients in the pharmaceutical ingredient data to be stored, combining the pharmaceutical ingredients with other pharmaceutical ingredients in a non-repeated mode to obtain all pharmaceutical ingredient combinations of the pharmaceutical ingredients, counting the simultaneous occurrence times of each pharmaceutical ingredient combination in all medicines in the pharmaceutical ingredient data to be stored, eliminating pharmaceutical ingredient combinations with the occurrence times of 0, and marking all other pharmaceutical ingredients except the pharmaceutical ingredients in the rest pharmaceutical ingredient combinations as target pharmaceutical ingredients of the pharmaceutical ingredients.
3. The intelligent storage management method for western medicine component data according to claim 1, wherein the method for obtaining the possibility of interaction between each medicine component and each target medicine component of each medicine component according to the content of each medicine component in each medicine comprises the following specific steps:
acquisition of the firstSeed drug ingredient and->First->Probability of co-occurrence of species target pharmaceutical ingredient; acquiring simultaneous presence of->Seed drug ingredient and->First->The content proportion of the seed target drug changes;will be->Seed drug ingredient and->First->The probability of co-occurrence of target pharmaceutical ingredient and the simultaneous presence of +.>Seed drug ingredient and->First->The ratio of the content proportion change degree of the seed target medicine is recorded as a first ratio; taking the first ratio after linear normalization as the +.>Seed drug ingredient and->First->There is a possibility of interaction between the target pharmaceutical ingredients.
4. The intelligent storage management method for western medicine composition data according to claim 3, wherein the acquiring the first stepSeed drug ingredient and->First->The specific formula of the probability of co-occurrence of the target drug components is as follows:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>Seed drug ingredient and->First->Probability of co-occurrence of species target pharmaceutical ingredient; />Indicating the simultaneous presence of +.>Drug ingredients of species and the firstFirst->Total number of drugs seeded with the target drug ingredient; />Indicating the presence of the first item in the pharmaceutical composition data to be storedTotal amount of drug of the seed drug component; />Indicating the presence of +.>First->Total amount of drug of the target drug component.
5. The intelligent storage management method for western medicine composition data according to claim 3, wherein the acquiring is carried out simultaneously with the first stepMedicinal ingredients of species and->First->The specific formula of the content proportion change degree of the target medicine component is as follows:
in the method, in the process of the invention,indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The content ratio of the two medicinal components in all medicaments for the target medicinal components varies; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Total number of drugs seeded with the target drug ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>The content of the seed medicine component; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->The>Drug of the seed>First->The content of the target pharmaceutical ingredient; />Indicating the simultaneous presence of +.>Medicinal ingredients of species and->First->Of all drugs of the target drug ingredient +.>Content of seed medicine component and->First->Average value of the ratio of the contents of the target pharmaceutical ingredient.
6. The intelligent storage management method for western medicine component data according to claim 1, wherein the method for obtaining the efficacy and effect degree of each medicine component in each medicine according to the possibility of interaction between each medicine component and each target medicine component of each medicine component comprises the following specific steps:
obtaining the efficacy action weight of each medicine component in each medicine according to the possibility of interaction between each medicine component and each target medicine component of each medicine component; the first of the pharmaceutical composition data to be storedThe seed medicine component is at->The calculation method of the efficacy and effect degree of the medicine comprises the following steps:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the pharmaceutical composition data to be storedFirst->The seed medicine component is at->The weight of the efficacy of the seed medicine; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The content of the medicine.
7. The intelligent storage management method for western medicine component data according to claim 6, wherein the method for obtaining the efficacy action weight of each medicine component in each medicine according to the possibility of interaction between each medicine component and each target medicine component of each medicine component comprises the following specific steps:
for the first of the pharmaceutical composition data to be storedDrug of the seed>A medicinal ingredient of the species, in->Obtaining the +.f from all the medicinal components of the seed medicine>All target pharmaceutical ingredients of the seed pharmaceutical ingredient, will be +.>Seed drug ingredient and->The mean value of the possibility of interaction between all target pharmaceutical ingredients of the species pharmaceutical ingredient is taken as +.>The seed medicine component is at->The weight of the efficacy of the medicine.
8. The intelligent storage management method for western medicine component data according to claim 1, wherein the acquiring the first pharmaceutical component data to be stored is characterized in thatThe seed medicine component is at->The specific formula of the difference of efficacy in the medicine is as follows:
in the method, in the process of the invention,representing the +.sup.th in the pharmaceutical composition data to be stored>The seed medicine component is at->The degree of efficacy achieved in the seed medicament; />Representing the +.sup.th in the pharmaceutical composition data to be stored>The average value of the degree of the efficacy of the drug ingredients in all drugs.
9. The intelligent storage management method for western medicine component data according to claim 1, wherein the classifying and storing of the pharmaceutical component data to be stored according to the degree of dispersion of the efficacy of the medicine comprises the following specific steps:
if the degree of dispersion of the drug efficacy of the pharmaceutical composition data to be stored is smaller thanThe pharmaceutical composition data to be stored is recorded as target pharmaceutical storage data; if the dispersion degree of the drug efficacy of the pharmaceutical ingredient data to be stored is greater than or equal to +.>Clustering the pharmaceutical composition data to be stored through an iterative self-organizing clustering algorithm to obtain a plurality of clustering clusters, and marking the clustering clusters as first clustering clusters; for any one first cluster, if the dispersion degree of the drug efficacy action of the first cluster is greater than or equal to +.>Clustering the first cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the first cluster, and marking the clusters as second cluster clusters; for any one of the second cluster of the first cluster, if the degree of dispersion of the drug efficacy effect of the second cluster is greater than or equal to +.>Clustering the second cluster by an iterative self-organizing clustering algorithm to obtain a plurality of clusters of the second clusterA cluster; and so on, until the degree of dispersion of the drug efficacy effect of all clusters is less than +.>Until that, each cluster obtained is taken as target medicine storage data; all of the drug components in each target drug storage data are stored together in a database.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311785210.1A CN117457114B (en) | 2023-12-25 | 2023-12-25 | Intelligent storage management method for western medicine pharmaceutical composition data |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311785210.1A CN117457114B (en) | 2023-12-25 | 2023-12-25 | Intelligent storage management method for western medicine pharmaceutical composition data |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117457114A CN117457114A (en) | 2024-01-26 |
| CN117457114B true CN117457114B (en) | 2024-03-12 |
Family
ID=89580313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311785210.1A Active CN117457114B (en) | 2023-12-25 | 2023-12-25 | Intelligent storage management method for western medicine pharmaceutical composition data |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117457114B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104346399A (en) * | 2013-08-06 | 2015-02-11 | 中国中医科学院西苑医院 | Method for analyzing basic data of Chinese herbal compound based on PK-PD (Pharmacokinetics-Pharmacodynamics) |
| CN104616233A (en) * | 2015-02-13 | 2015-05-13 | 杜雨阳 | Method and system of obtaining interaction prompt information between medicines |
| CN105142638A (en) * | 2013-03-15 | 2015-12-09 | 维罗纳制药公司 | Drug combination |
| US10026137B1 (en) * | 2010-11-17 | 2018-07-17 | Express Scripts Strategic Development, Inc. | Computer system and computer implemented method for real-time drug interaction checker |
| WO2020052312A1 (en) * | 2018-09-14 | 2020-03-19 | 北京三快在线科技有限公司 | Positioning method and apparatus, electronic device, and readable storage medium |
| CN116631563A (en) * | 2023-07-21 | 2023-08-22 | 北京杏林康云信息科技股份有限公司 | Big data storage and intelligent matching method for pharmaceutical industry |
| CN117216131A (en) * | 2023-11-07 | 2023-12-12 | 深圳市前海蛇口自贸区医院(深圳市南山区蛇口人民医院) | Traditional Chinese medicine data management system based on data retrieval |
-
2023
- 2023-12-25 CN CN202311785210.1A patent/CN117457114B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10026137B1 (en) * | 2010-11-17 | 2018-07-17 | Express Scripts Strategic Development, Inc. | Computer system and computer implemented method for real-time drug interaction checker |
| CN105142638A (en) * | 2013-03-15 | 2015-12-09 | 维罗纳制药公司 | Drug combination |
| CN104346399A (en) * | 2013-08-06 | 2015-02-11 | 中国中医科学院西苑医院 | Method for analyzing basic data of Chinese herbal compound based on PK-PD (Pharmacokinetics-Pharmacodynamics) |
| CN104616233A (en) * | 2015-02-13 | 2015-05-13 | 杜雨阳 | Method and system of obtaining interaction prompt information between medicines |
| WO2020052312A1 (en) * | 2018-09-14 | 2020-03-19 | 北京三快在线科技有限公司 | Positioning method and apparatus, electronic device, and readable storage medium |
| CN116631563A (en) * | 2023-07-21 | 2023-08-22 | 北京杏林康云信息科技股份有限公司 | Big data storage and intelligent matching method for pharmaceutical industry |
| CN117216131A (en) * | 2023-11-07 | 2023-12-12 | 深圳市前海蛇口自贸区医院(深圳市南山区蛇口人民医院) | Traditional Chinese medicine data management system based on data retrieval |
Non-Patent Citations (1)
| Title |
|---|
| 浅析中西药不合理应用引起的毒副作用;韩莹;;求医问药(下半月);20121201(12);第449-450页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117457114A (en) | 2024-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2595615A (en) | Managing data objects for graph-based data structures | |
| CN102693286B (en) | Method for organizing and managing file content and metadata | |
| CN115276665B (en) | Intelligent management method and system for bulk drugs | |
| US8745021B2 (en) | Transformation of complex data source result sets to normalized sets for manipulation and presentation | |
| CN104252526B (en) | The remote measurement storage method eliminated based on redundancy | |
| Sharma | An extended classification and comparison of nosql big data models | |
| CN117216131B (en) | Traditional Chinese medicine data management system based on data retrieval | |
| CN108897789A (en) | A kind of cross-platform social network user personal identification method | |
| CN103207889A (en) | Method for retrieving massive face images based on Hadoop | |
| CN117457114B (en) | Intelligent storage management method for western medicine pharmaceutical composition data | |
| CN106022004A (en) | Method and system for detecting mixed drug conflict | |
| CN109144958A (en) | A kind of union file system file access frequency metadata acquisition method and device | |
| CN101625677A (en) | Graph processing system | |
| CN107861965A (en) | Data intelligence recognition methods and system | |
| CN113963771A (en) | Method and device for calculating medicine opening quantity, electronic equipment and storage medium | |
| CN107894875A (en) | A kind of RTU date storage methods | |
| CN116881252A (en) | Key value storage method and system based on LSM tree | |
| CN116205235A (en) | Data set dividing method and device and electronic equipment | |
| CN109215747A (en) | A kind of medical data base with function of statistic analysis | |
| CN107247741A (en) | A kind of concentrating type textual magnanimity sensitive data processing method and system | |
| CN108985811A (en) | Method, apparatus and electronic equipment for precision marketing | |
| CN106502625A (en) | The evaluation method of top n cardinal datas in a kind of high-speed data-flow | |
| CN113076396A (en) | Entity relationship processing method and system oriented to man-machine cooperation | |
| CN111062751A (en) | Charging system and method based on automatic drug correlation consumable | |
| CN106850274B (en) | It is a kind of for issuing the intelligent packet method and apparatus of Beidou ground strengthening system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |